Veterinary Sciences Post-Graduation Program (PPGCV), Veterinary Faculty, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.
Hormone Laboratory, Provet - Medicina Veterinária Diagnóstica, São Paulo, Brazil.
Domest Anim Endocrinol. 2024 Oct;89:106880. doi: 10.1016/j.domaniend.2024.106880. Epub 2024 Aug 13.
Porcine adrenocorticotrophic hormone (ACTH) has been considered valid for the ACTH stimulation test (ACTHST) in humans and dogs; however, its safety and efficacy for use in cats are unknown. Also, the equivalence between 5 µg/kg and 125 µg/cat dose of synthetic corticotropin (1-24 ACTH - cosyntropin/tetracosactide) is assumed for ACTHST in cats. This study evaluated the safety and effectiveness of different porcine recombinant ACTH doses for the ACTHST in healthy cats and its equivalence with tetracosactide. The study was divided into two arms. The first evaluated safety and equivalence of intravenous 1 µg/kg, 5 µg/kg, or 125 µg/cat porcine ACTH in seven healthy cats for the ACTHST evaluating basal and post-ACTH androstenedione, aldosterone, cortisol, and progesterone concentrations. In the second arm, the equivalence of the 125 µg/cat porcine ACTH dose was evaluated compared to results obtained using 125 µg/cat of tetracosactide in ten healthy cats regarding cortisol responses. In all tests, several cat-friendly strategies were adopted, and the ACTHST protocol involved basal and 60-minute post-ACTH blood sampling and intravenous ACTH injection. No adverse reactions were documented, and no tested cat showed any complications during the study. No porcine ACTH tested dose significantly increased androstenedione secretion. In contrast, all tested doses were able to increase progesterone concentration significantly (P < 0.05), and Δ-progesterone in response to 5 µg/kg or 125 µg/cat was considered equivalent (P > 0.99). The 125 µg/cat dose promoted greater responses for both cortisol and aldosterone, characterized by Δ-cortisol (P = 0.009) and Δ-aldosterone (P = 0.004). Despite equivalent Δ-cortisol results in response to 5 µg/kg or 125 µg/cat (P = 0.18); post-ACTH results of cortisol in response to 5 µg/kg only approximate statistical significance when compared with basal (P = 0.07). Porcine ACTH and tetracosactide significantly increased post-ACTH cortisol concentration (P < 0.0001) while the Δ-cortisol was slightly greater in response to the porcine ACTH (P = 0.006). These results suggest porcine ACTH could be an alternative source of corticotropin for the ACTHST in cats; however, maximum corticoadrenal stimulation seemed more reliable in response to a 125 µg/cat regarding cortisol and aldosterone.
猪促肾上腺皮质激素(ACTH)一直被认为可用于人类和犬的 ACTH 刺激试验(ACTHST);然而,其在猫中的安全性和有效性尚不清楚。此外,对于猫的 ACTHST,假定 5µg/kg 和 125µg/猫剂量的合成促皮质素(1-24 ACTH-促皮质素/四肽促皮质素)等效。本研究评估了不同剂量猪重组 ACTH 用于健康猫 ACTHST 的安全性和有效性,以及与四肽促皮质素的等效性。该研究分为两个部分。第一部分评估了静脉内 1µg/kg、5µg/kg 或 125µg/猫猪 ACTH 在 7 只健康猫中的安全性和等效性,用于评估 ACTHST 基础和 ACTH 后雄烯二酮、醛固酮、皮质醇和孕酮浓度。在第二部分中,评估了 125µg/猫猪 ACTH 剂量与 125µg/猫四肽促皮质素在 10 只健康猫中获得的皮质醇反应的等效性。在所有测试中,采用了多种猫友好型策略,ACTHST 方案包括基础和 60 分钟后 ACTH 采血和静脉内 ACTH 注射。未记录到不良反应,并且在研究过程中没有测试猫出现任何并发症。没有测试的猪 ACTH 剂量显著增加雄烯二酮的分泌。相反,所有测试剂量均能显著增加孕酮浓度(P<0.05),并且 5µg/kg 或 125µg/猫的Δ-孕酮被认为等效(P>0.99)。125µg/猫的剂量促进了皮质醇和醛固酮的更大反应,表现为Δ-皮质醇(P=0.009)和Δ-醛固酮(P=0.004)。尽管 5µg/kg 或 125µg/猫的反应中Δ-皮质醇等效(P=0.18);但与基础相比,5µg/kg 后皮质醇的 ACTH 后反应仅接近统计学意义(P=0.07)。猪 ACTH 和四肽促皮质素显著增加了 ACTH 后皮质醇浓度(P<0.0001),而猪 ACTH 反应的Δ-皮质醇略高(P=0.006)。这些结果表明,猪 ACTH 可能是猫 ACTHST 的另一种促皮质素来源;然而,关于皮质醇和醛固酮,125µg/猫的皮质肾上腺刺激似乎更可靠。